Comments

PMV Pharma

PMVPNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.59
-0.02-1.24%
At Close: -
$1.68
0.095.66%
After Hours: Jul 17, 9:10 AM EDT
15 minutes delayed
PMV Pharma (PMVP) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$56.00
Lowest Price Target1
$5.00
Consensus Price Target1
$17.00

want to know what
the Bulls & Bears Say?

PMV Pharma (NASDAQ:PMVP) Stock, Analyst Ratings, Price Targets, Forecasts

PMV Pharmaceuticals Inc has a consensus price target of $17 based on the ratings of 7 analysts. The high is $56 issued by Guggenheim on August 2, 2021. The low is $5 issued by HC Wainwright & Co. on May 30, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Craig-Hallum on May 30, 2024, May 14, 2024, and May 13, 2024, respectively. With an average price target of $5.33 between HC Wainwright & Co., HC Wainwright & Co., and Craig-Hallum, there's an implied 217.46% upside for PMV Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
Apr
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Craig-Hallum
Jefferies
Ladenburg Thalmann
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for PMV Pharma

Buy NowGet Alert
05/30/2024Buy Now197.62%HC Wainwright & Co.
Robert Burns
$5 → $5ReiteratesBuy → BuyGet Alert
05/14/2024Buy Now197.62%HC Wainwright & Co.
Robert Burns
 → $5ReiteratesBuy → BuyGet Alert
05/13/2024Buy Now257.14%Craig-Hallum
Albert Lowe
 → $6Initiates → BuyGet Alert
04/12/2024Buy Now197.62%Jefferies
Kambiz Yazdi
 → $5Initiates → BuyGet Alert
03/07/2024Buy Now197.62%HC Wainwright & Co.
Robert Burns
 → $5ReiteratesBuy → BuyGet Alert
12/27/2023Buy Now316.67%Ladenburg Thalmann
Aydin Huseynov
 → $7Initiates → BuyGet Alert
10/16/2023Buy Now197.62%HC Wainwright & Co.
Robert Burns
$29 → $5MaintainsBuyGet Alert
08/11/2023Buy Now1626.19%HC Wainwright & Co.
Robert Burns
$35 → $29MaintainsBuyGet Alert
05/17/2023Buy Now1983.33%HC Wainwright & Co.
Robert Burns
 → $35ReiteratesBuy → BuyGet Alert
05/11/2023Buy Now792.86%Oppenheimer
Jeff Jones
 → $15ReiteratesOutperform → OutperformGet Alert
03/20/2023Buy Now1983.33%HC Wainwright & Co.
Robert Burns
$36 → $35MaintainsBuyGet Alert
03/02/2023Buy Now792.86%Oppenheimer
Jeff Jones
$28 → $15MaintainsOutperformGet Alert
11/17/2022Buy Now2042.86%HC Wainwright & Co.
Robert Burns
$63 → $36MaintainsBuyGet Alert
06/09/2022Buy Now1864.29%Oppenheimer
Jeff Jones
$30 → $33MaintainsOutperformGet Alert
05/24/2022Buy Now1388.1%Goldman Sachs
Paul Choi
$43 → $25MaintainsBuyGet Alert
03/02/2022Buy Now—Oppenheimer
Jeff Jones
—UpgradePerform → OutperformGet Alert
09/22/2021Buy Now2459.52%Goldman Sachs
Paul Choi
—UpgradeNeutral → BuyGet Alert
08/19/2021Buy Now—Oppenheimer
Jeff Jones
—Initiates → PerformGet Alert
08/02/2021Buy Now3233.33%Guggenheim
Charles Zhou
—Initiates → BuyGet Alert
07/29/2021Buy Now3650%HC Wainwright & Co.
Robert Burns
—Initiates → BuyGet Alert

FAQ

Q

What is the target price for PMV Pharma (PMVP) stock?

A

The latest price target for PMV Pharma (NASDAQ:PMVP) was reported by HC Wainwright & Co. on May 30, 2024. The analyst firm set a price target for $5.00 expecting PMVP to rise to within 12 months (a possible 197.62% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for PMV Pharma (PMVP)?

A

The latest analyst rating for PMV Pharma (NASDAQ:PMVP) was provided by HC Wainwright & Co., and PMV Pharma reiterated their buy rating.

Q

When was the last upgrade for PMV Pharma (PMVP)?

A

The last upgrade for PMV Pharmaceuticals Inc happened on March 2, 2022 when Oppenheimer raised their price target to N/A. Oppenheimer previously had a perform for PMV Pharmaceuticals Inc.

Q

When was the last downgrade for PMV Pharma (PMVP)?

A

There is no last downgrade for PMV Pharma.

Q

When is the next analyst rating going to be posted or updated for PMV Pharma (PMVP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PMV Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PMV Pharma was filed on May 30, 2024 so you should expect the next rating to be made available sometime around May 30, 2025.

Q

Is the Analyst Rating PMV Pharma (PMVP) correct?

A

While ratings are subjective and will change, the latest PMV Pharma (PMVP) rating was a reiterated with a price target of $5.00 to $5.00. The current price PMV Pharma (PMVP) is trading at is $1.68, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch